Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | MIRO | Series B-2 Preferred Stock | Jun 23, 2021 | Common Stock | 933K | Direct | F1, F2 | |||||||
holding | MIRO | Warrants | Jun 23, 2021 | Series C Preferred Stock | 240K | Direct | F2, F3 | |||||||
holding | MIRO | Convertible Promissory Note | Jun 23, 2021 | Series C Preferred Stock | 957K | Direct | F2, F4 |
Id | Content |
---|---|
F1 | Each share of Series B-2 Preferred Stock will automatically convert into shares of Common Stock upon the closing of the Issuer's Initial Public Offering ("IPO"). |
F2 | As a result of DaVita Inc.'s ownership interest in Cheshire MD Holdings, LLC, DaVita Inc. may be deemed to have an indirect pecuniary interest in the shares held directly by Cheshire MD Holdings, LLC. |
F3 | The Warrants will be exercised for 240,000 shares of Series C Preferred Stock immediately prior to the underwriting agreement being signed in connection with Issuer's IPO. |
F4 | The Convertible Promissory Note will convert into 956,887 shares of Series C Preferred Stock immediately prior to the underwriting agreement being signed in connection with the Issuer's IPO. |